What is the current market price of evantuzumab? Are there big price differences between different channels?

Amivantamab is a monoclonal antibody that targets specific epidermal growth factor receptor (EGFR) mutations and is used to treat certain types of non-small cell lung cancer (NSCLC). This drug inhibits the growth and spread of tumor cells by targeting the EGFR and MET pathways. The unique feature of evantumumab is that it not only targets EGFR mutations, but also can combat tumors that are resistant to traditional EGFR inhibitors, providing patients with new treatment options.

Evantumumab will be launched in China in early 2025. Although it has been on the market for a short time, its clinical application prospects are broad. However, as it has just been launched, domestic patients may face difficulties in obtaining this drug. When considering a purchase, patients can look for overseas versions. According to our understanding, the original research version of evantumumab sells for about 10,000 yuan in China. This price is still a big burden for many patients.

In the international market, evantumumab has also been approved and is sold in some countries such as the United States and the European Union. The specifications of original drugs in these areas are generally 350mg, and the price of each box may be around 20,000 yuan. Please note that this price is subject to exchange rate fluctuations, so the actual amount paid may vary. In these countries, the availability of evantumumab is relatively high, and patients can purchase it through formal channels.

The launch of evantumumab brings new hope to patients with non-small cell lung cancer, especially those who have responded poorly to traditional treatments. With the accumulation of clinical trials and use experience, medical staff have gradually increased their confidence in the effectiveness of the drug. At the same time, the launch of drugs is also accompanied by improvements in patient education and support services to help patients better understand their treatment options and possible side effects.

Reference materials:https://www.rybrevant.com/